Core Viewpoint - Fuxing Asia (00274.HK) has announced that its annual results for 2024/25 will be further delayed until on or before September 30, 2025 [1] Group 1 - The company has been making efforts to address the auditor's requirements over the past few days but needs additional time to provide all necessary documents required by its Chinese legal advisor [1] - As of the date of the announcement, all necessary documents requested by the auditor have been provided, and it is expected that the company's Chinese legal advisor will complete and issue the legal opinion in the short term [1] - The company's shares remain suspended from trading [1]

本公司谨此 此提供最新 新情况如下 ： 終止綜合 入賬附屬公 公司 香港交易及 整性亦不發 容而引致之 及結算所有限 發表任何聲明 之任何損失承 限公司及香港 明，並明確表 承擔任何責任 港聯合交易 表示，概不 任。 易所有限公司 不就因本公告 司對本公告之 告全部或任何 之內容概不負 何部份內容而 負責，對其準 而產生或因倚 其準確性或完 因倚賴該等內 完 內 （ 於開曼群 群島註冊成立之 之有限公司） （ 股 股份代號：2 274） (1)進一步 步延遲刊 (2)繼 刊發2024/ 及 繼續暫停 /25年年度 買賣 度業績； 茲提述復 為2025年7 括）延遲刊 有相同涵義 興亞洲絲路 7月2日、20 刊發2024/25 義。 路集團有限 025年8月7 5年年度業 限公司（「 日及2025年 績。除另有 本公司」 年8月28日的 有所指外， ，連同其附 公告（「該 本公告所 附屬公司，統 等公告」） 所用詞彙與該 統稱「本集 ，內容有關 該等公告所 集團」）日期 關（其中包 所界定者具 期 包 具 1 於過去數天已盡最大努力處理核數師的該等要求，但仍需額外時間提供本公司中國法 律顧問所需的所有必要文件， ...

致：香港交易及結算所有限公司 公司名稱: 復興亞洲絲路集團有限公司 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00274 | 說明 | 普通股 | | | | | | | | 多櫃檯證券代號 | | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 500,000,000 | HKD | | 0.5 HKD | | | 250,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | | 本月底結存 | | | 500,000,000 | HKD | | 0.5 HKD | | | 250,0 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致之任何損失承擔任何責任。 （於開曼群島註冊成立之有限公司） 進一步延遲刊發2024/25年年度業績 董事會謹此宣佈，2024/25年年度業績將進一步延遲至2025年9月30日或之前刊發。本 公司於過去數天已盡最大努力處理核數師的該等要求，但仍需額外時間提供本公司 中國法律顧問所需的所有必要文件，供其出具回應該等要求的法律意見。於本公告 日期，核數師要求的所有必要文件已獲提供，預期本公司的中國法律顧問能夠在短 期內完成並出具法律意見。 繼續暫停買賣 本公司股份已於2025年7月2日上午九時正起於聯交所暫停買賣，並將繼續暫停買 賣，直至本公司刊發2024/25年年度業績為止。 1 本公司股東及潛在投資者於買賣本公司證券時務請審慎行事。 承董事會命 復興亞洲絲路集團有限公司 執行董事 王雅娟 （股份代號：274） (1)進一步延遲刊發2024/25年年度業績； 及 (2)繼續暫停買賣 茲提述復興亞洲絲路集團有限公司（「本公司」，連同其 ...

Group 1 - The stock price of *ST San Sheng (002742) closed at 4.8 yuan, down 3.03%, with a turnover rate of 4.16% and a trading volume of 179,700 hands, amounting to 87.37 million yuan [1] - The net outflow of main funds today was 15.92 million yuan, accounting for 18.23% of the transaction amount, with large orders seeing a net outflow of 9.31 million yuan (10.66%) and 6.61 million yuan (7.57%) respectively [1] - The latest financial report shows that the total operating revenue for the first quarter of 2025 was 235 million yuan, a year-on-year decrease of 32.52%, and the net profit attributable to shareholders was 82.38 million yuan, down 132.59% [1] Group 2 - Chongqing San Sheng Industrial Co., Ltd. was established in 2002 and is primarily engaged in the non-metallic mineral products industry, with a registered capital of 432 million yuan and paid-in capital of 72.16 million yuan [1] - The company has made investments in 21 enterprises and participated in 69 bidding projects, holding 53 trademark registrations and 70 patents, along with 114 administrative licenses [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致之任何損失承擔任何責任。 （於開曼群島註冊成立之有限公司） 有關 延遲刊發2024/25年年度業績 及 繼續暫停買賣 之補充公告 本公告由復興亞洲絲路集團有限公司（「本公司」，連同其附屬公司，統稱「本集團」） 根據香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市規則」）第13.09條以及 香港法例第571章證券及期貨條例第XIVA部項下之內幕消息條文（定義見上市規則） 作出。 茲提述(i)本公司日期為2024年9月3日的公告（「24年9月公告」），內容有關就本集團欠 付蔡先生的逾期貸款而向本公司發出的傳訊令狀；(ii)本公司日期為2025年1月14日 的公告（「25年1月公告」），內容有關（其中包括）湖南西澳的相關股東發出的函件，當 中提述本公司已失去對湖南西澳的控制權；及(iii)本公司日期為2025年7月2日的公告 （「延遲公告」），內容有關（其中包括）延遲刊發2024/25年年度業績。除另有界定外， 本公告所用詞彙 ...

Group 1 - The Hang Seng Index rose by 1.63% to close at 24,181.43 points on June 9 [1] - Fuxing Asia (00274.HK) closed at HKD 0.71 per share, up 43.43%, with a trading volume of 15.06 million shares and a turnover of HKD 9.32 million, showing a volatility of 63.64% [1] - Over the past month, Fuxing Asia has seen a cumulative increase of 59.68%, but a year-to-date decline of 51.11%, underperforming the Hang Seng Index by 18.61% [1] Group 2 - For the fiscal year ending September 30, 2024, Fuxing Asia reported total revenue of HKD 304 million, a year-on-year increase of 309.94%, and a net profit attributable to shareholders of HKD -21.82 million, a year-on-year increase of 1.05% [1] - The gross profit margin stands at 2.79%, with a debt-to-asset ratio of 62.25% [1] - Currently, there are no institutional investment ratings for Fuxing Asia [2] Group 3 - The average price-to-earnings (P/E) ratio for the gold and precious metals industry is 33.2 times, with a median of 29.96 times [2] - Fuxing Asia has a P/E ratio of -1.01 times, ranking 14th in the industry [2] - Other companies in the industry include Zijin Mining (02899.HK) with a P/E of 12.59 times, Long Resources (01712.HK) at 13.19 times, and others with varying P/E ratios [2] Group 4 - Fuxing Asia Silk Road Group Limited primarily engages in mining and cosmetics businesses, operating through two main segments: mining products and cosmetics and skincare products [2]

Core Viewpoint - Three A-shares are set to remove their delisting risk warnings, indicating improvements in their fundamentals through various strategies such as focusing on core businesses and restructuring efforts [1][10][11] Group 1: Company Announcements - *ST Nongshang announced that its stock will remove the delisting risk warning and change its name to "Nongshang Environment," with trading resuming on May 23, 2025 [1][7] - *ST Jinshi will also remove its delisting risk warning and change its name to "Jinshi Technology," with trading resuming on May 23, 2025 [1][10] - ST Shilong will remove other risk warnings and change its name to "Shilong Industry," with trading resuming on May 22, 2025 [1][3] Group 2: Financial Performance and Compliance - ST Shilong faced penalties for false trade activities that inflated revenue and profits in 2019 and 2020, leading to a risk warning in 2024 [3][4] - ST Nongshang reported a 2024 revenue of 218 million yuan and a net asset of 524 million yuan, with a standard unqualified audit report [7][8] - *ST Jinshi reported a 2024 net profit of -1622.48 million yuan and a revenue of 370 million yuan, while also divesting its subsidiary to improve its financial position [11][12] Group 3: Strategic Actions - Companies are adopting various strategies such as asset optimization and business transformation to enhance their operational capabilities and remove risk warnings [1][11][12] - ST Nongshang has focused on developing its computing power service business, which generated 108 million yuan in revenue, accounting for 46.66% of total revenue [8] - *ST Jinshi has implemented a strategic transformation by investing in new production lines for energy storage systems and has reported significant revenue from these new ventures [12]

Group 1 - ST Shilong announced that it will remove the other risk warning from its stock starting May 22, changing its name from "ST Shilong" to "Shilong Industrial," while the stock code remains "002748" [2] - Following the removal of the risk warning, the daily price fluctuation limit for the stock will increase from 5% to 10% [2] - The stock will be suspended for trading on May 21 and will resume trading on May 22 [2] Group 2 - ST Shilong received an administrative penalty notice from the Jiangxi Regulatory Bureau of the China Securities Regulatory Commission (CSRC) on March 12, 2024, for falsely inflating revenue and profits through non-existent trade activities from 2019 to 2020 [5] - The company has restated its financial reports for the affected years and received an unqualified audit report [5] - As of May 17, 2024, the stock was subjected to "other risk warnings" again, reverting to "ST Shilong" [5] Group 3 - ST Shilong is a comprehensive chemical enterprise primarily engaged in the research, production, and sales of chemical products such as AC foaming agents, thionyl chloride, chlor-alkali, hydrazine hydrate, and hydrogen peroxide [6] - In the first quarter of 2025, the company reported revenue of 507 million yuan, an increase of 8.32% year-on-year, and a net profit attributable to shareholders of 24.17 million yuan, up 342.56% year-on-year [6][7] - As of May 20, the stock price closed at 9.18 yuan per share, with a total market capitalization of 2.2 billion yuan [8]

Financial Position - As of September 30, 2024, the company's cash and bank balances were approximately HKD 6.8 million, down from HKD 10.1 million as of March 31, 2024[3] - The company's borrowings were approximately HKD 106.9 million as of September 30, 2024, a decrease from HKD 186.9 million as of March 31, 2024[3] - The net current liabilities recorded as of September 30, 2024, were approximately HKD 66.8 million, compared to HKD 140.8 million as of March 31, 2024[3] - The net asset value was approximately HKD 114.2 million as of September 30, 2024, an increase from HKD 40.5 million as of March 31, 2024[3] Liquidation and Financial Support - The company believes that the ongoing liquidation petition, involving claims of approximately HKD 3 million, will not have a significant impact on its operations[6] - The main shareholder, holding approximately 10.3% of the issued shares, has committed to providing financial support[6] - The company is in continuous discussions with several creditors regarding debt capitalization to strengthen its financial position[6] - The company plans to apply for a validation order from the Hong Kong High Court by the end of January 2025[6] - The company cannot guarantee that the Hong Kong High Court will issue the validation order or that any application will be successful[10] - The company will issue further announcements if there are any significant developments regarding the liquidation petition[10]